A two-gene signature based on KLK3 and BIRC5 expression was evaluated for predicting circulating tumour cell (CTC) levels in metastatic castration-resistant PCa (mCRPC) that produced an AUC of 0.74 from a set of 29 mCRPC and 19 healthy individuals (12). The gene discussed is BIRC5; the disease is neoplasm.